Caris Life Sciences (CAI) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Caris Life Sciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $1.6M and 4 sold $28.9M of CAI stock on the open market.
Get emailed when insiders cluster-buy stocks like CAI
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
CAI insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $27.2M | 5 |
| Q2 2026 | $1.5M | 2 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $110K | 2 | $1.7M | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 3 Caris Life Sciences, Inc. insiders reported open-market purchases totaling $1.6M, while 4 insiders reported sales totaling $28.9M. 2 of 7 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 23SEC | John Russel DentonSee Remarks | Sell | 7,500174,855 held (−4%) | $31.82 | $239K | -6.7% | — |
| Sep 17SEC | Brian J BrilleSee Remarks | Sell | 400,000230,303 held (−63%) | $30.33 | $12.1M | -2.1% | — |
| Sep 4SEC | David Baxley SpetzlerPresident | Sell | 393,1001,136,983 held (−26%) | $24.76 | $9.7M | +20.0% | — |
| Sep 4SEC | David Baxley SpetzlerPresident | Sell | 119,2121,182,871 held (−9%) | $24.76 | $3.0M | +20.0% | — |
| Sep 4SEC | David Baxley SpetzlerPresident | Sell | 84,9001,052,083 held (−7%) | $25.32 | $2.1M | +17.3% | — |
| Jul 13SEC | Jon HalbertDirector | Buy | 68,000704,598 held (+11%) | $14.56 | $990K | +104.0% | — |
| May 12SEC | Jeff L VacircaDirector | Buy | 31,05049,671 held (+167%) | $16.15 | $501K | +83.9% | — |
| Dec 12SEC | Luke Thomas PowerSee Remarks | Sell Plan | 60,850100,971 held (−38%) | $26.56 | $1.6M | +11.8% | — |
| Dec 12SEC | Luke Thomas PowerSee Remarks | Sell Plan | 1,40099,571 held (−1%) | $27.16 | $38K | +9.4% | — |
| Nov 10SEC | John Russel DentonSee Remarks | Buy | 4,1849,184 held (+84%) | $24.09 | $101K | +23.3% | — |
| Nov 10SEC | David Baxley SpetzlerPresident | Buy | 400460,777 held (+0%) | $23.85 | $10K | +24.5% | — |
Insiders at Caris Life Sciences, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| David Baxley SpetzlerPresident | $10K | $14.8M | Sep 4, 2026 | — |
| Brian J BrilleSee Remarks | — | $12.1M | Sep 17, 2026 | — |
| Jon HalbertDirector | $990K | — | Jul 13, 2026 | — |
| Luke Thomas PowerSee Remarks | — | $1.7M | Dec 12, 2025 | — |
| Jeff L VacircaDirector | $501K | — | May 12, 2026 | — |
| John Russel DentonSee Remarks | $101K | $239K | Sep 23, 2026 | — |
CAI stock: common questions
Are Caris Life Sciences, Inc. insiders buying CAI stock?
In the past 12 months, 3 insiders reported open-market purchases of CAI worth $1.6M. The latest was Director Jon Halbert bought $990K of CAI at $14.56 — first open-market purchase in our records.
Are Caris Life Sciences, Inc. insiders selling CAI stock?
4 insiders reported sales worth $28.9M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CAI's 52-week range?
Over the past year CAI has traded between $14.55 and $32.27. It last closed at $29.70 on Oct 9, 2026.